<DOC>
	<DOCNO>NCT02779530</DOCNO>
	<brief_summary>Randomized , double-blinded , cross-over placebo control clinical trial evaluate association genetic polymorphism CYP4F2 cardiovascular adverse effect non-steroidal anti-inflammatory drug ( NSAIDs ) . Two group include accord CYP4F2 V433M genetic polymorphism ( control - MM , N=7 vs. VV VM variant , N=13 ) . According sample size plan , mean difference total body water delta group ( control vs. polymorphic ) least allow 10 % could observe .</brief_summary>
	<brief_title>CYP4A11 CYP4F2 Gene Variants Makers Cardiovascular Adverse Events Non-steroidal Anti-inflammatory Drugs</brief_title>
	<detailed_description />
	<mesh_term>Drug-Related Side Effects Adverse Reactions</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<mesh_term>Anti-Inflammatory Agents , Non-Steroidal</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<criteria>Healthy volunteer 1865 yearsold Use drug without clinical history adverse effect NSAIDS</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>